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Introduction: Antimicrobial resistance (AMR), associated with antimicrobial use (AMU),
is a major public concern. Surveillance and monitoring systems are essential to assess and
control the trends in AMU and AMR. However, differences in the surveillance and monitor-
ing systems between countries and sectors make comparisons challenging. The purpose of
this article is to describe all surveillance and monitoring systems for AMU and AMR in the
human and livestock sectors, as well as national surveillance and monitoring systems for
AMR in food, in six European countries (Spain, Germany, France, the Netherlands, the
United Kingdom and Norway) as a baseline for developing suggestions to overcome current
limitations in comparing AMU and AMR data.
Methods: A literature search in 2018 was performed to identify relevant peer-reviewed
articles and national and European grey reports as well as AMU/AMR databases.
Results: Comparison of AMU and AMR systems across the six countries showed a lack of
standardization and harmonization with different AMU data sources (prescription vs sales
data) and units of AMU and AMR being used. The AMR data varied by sample type
(clinical/non-clinical), laboratory method (disk diffusion, microdilution, and VITEK,
among others), data type, ie quantitative (minimum inhibition concentration (MIC) in mg/
L/inhibition zone (IZ) in mm) vs qualitative data (susceptible-intermediate-resistant (SIR)),
the standards used (EUCAST/CLSI among others), and/or the evaluation criteria adopted
(epidemiological or clinical).
Discussion: A One Health approach for AMU and AMR requires harmonization in various
aspects between human, animal and food systems at national and international levels.
Additionally, some overlap between systems of AMU and AMR has been encountered.
Efforts should be made to improve standardization and harmonization and allow more
meaningful analyses of AMR and AMU surveillance data under a One Health approach.
Keywords: AMR, AMU, food-producing animals, harmonization, monitoring, surveillance
Introduction
Antimicrobial use (AMU) in the last few decades is the main trigger for antimi-
crobial resistance (AMR) in humans and animals. For example, broad use of
fluoroquinolones, effective antimicrobials against gram-positive and gram-
negative bacteria, in humans and some animal populations has caused high resis-
tance rates.1 Antibiotics like colistin, that have issues with side effects but still have
low resistance rates, have been reconsidered as a last-line drug due to a lack of
alternative antimicrobials for multidrug-resistant Gram-negative bacteria.2 This
global threat includes both pathogenic and commensal bacteria. In order to tackle
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the AMR crisis, several global strategies have been devel-
oped such as the Global Action Plan (GAP) of the World
Health Organization (WHO),3 the new European One
Health Action Plan against AMR4 and the Central Asian
and Eastern European Surveillance of Antimicrobial
Resistance network (CAESAR).5
Surveillance6 and monitoring6 systems of AMU and
AMR in humans and animals are essential to assess and
subsequently control the global trends in the use of anti-
microbials and antimicrobial susceptibility patterns of bac-
teria in different populations.7 Using a One Health
approach, zoonotic and indicator bacteria are of particular
relevance.
Surveillance and monitoring systems are one of the five
strategies of the GAP. However, even when the proper
implementation of these systems enables the collection of
reliable and good quality data, not all countries worldwide
have surveillance and monitoring systems in place so it is
not possible to perform a global comparison.
Several projects address the systems' evaluation of AMU
andAMR in human, livestock and food sectors in Europe and
also across European countries. As an illustration, the
Ecology from Farm to Fork Of microbial drug Resistance
and Transmission (EFFORT) project8 is a relevant work
collecting AMU and AMR data from broilers, pigs, turkeys,
veal calves, rainbow trout and companion animals at farm
level across different EU countries. Additionally, the
Antibiotic Resistance Dynamics: the influence of geographic
origin and management systems on resistance gene flows
within humans, animals and the environment (ARDIG)9
project gathers AMU and AMR data from the human and
animal sectors together with AMR data collection from food
at European level. Likewise, another crucial work carried out
at global level and in the animal sector is the Network on
quantification of veterinary Antimicrobial usage at herd level
and Analysis, CommunicaTion and benchmarkING to
improve responsible usage (AACTING).10 The latter initia-
tive has generated a review of existing systems that collect
AMU data at farm level.
This report follows on the work carried out in the
ARDIG project and provides a review of AMU and AMR
surveillance and monitoring systems, adopting a One
Health approach, currently available in six European coun-
tries that perform routine surveillance, as well as systems at
a European level.
It will make recommendations regarding the harmoni-
zation of surveillance and monitoring systems across
Europe with a view to help overcome current limitations
in comparing AMU and AMR data captured by these
systems from different sectors and countries within
Europe.
Materials and Methods
In this manuscript, we gathered key features of surveil-
lance and monitoring systems on AMU and AMR in live-
stock and humans as well as AMR systems in food from
Spain, Germany, France, the Netherlands, Norway, the
United Kingdom (UK) together with its regions and
Europe between 2014 and 2017.
A literature search in 2018 was performed using
PubMed to identify relevant peer-reviewed articles and
the internet to identify national and European grey reports
as well as AMU/AMR databases. The terms used for the
search are “antimicrobial resistance”, “antimicrobial use”,
“Spain”, “Germany”, “UK”, “United Kingdom”,
“Scotland”, “Wales”, “England”, “Northern Ireland”,
“Netherlands”, “France”, “Norway”, “Europe”, “food”,
“human”, “animal”, “surveillance”, “system” and “moni-
toring”. Additionally, a questionnaire asking for detailed
information on any available AMR and AMU database in
each country was developed and sent to all collaborating
institutes for completion (Supplementary materials).
A detailed systems' description by country and sector
has been performed in order to detect and define the lack
of harmonization and standardization on AMU and AMR.
Results
Antimicrobial Resistance Surveillance and
Monitoring Systems
A general overview on AMR monitoring and surveillance
systems is provided in Table 1. The variables collected in
the table are the country/region, database name, data type,
data origin, unit, interpretation standard, evaluation cri-
teria, public data, published report, report language, sub-
mitting data to Europe, laboratory method and set-up year
of the database. Additionally, Figures 1–3, showing AMR
systems reporting and not reporting to EU per country and
sector, are provided.
Europe
The European Food Safety Authority (EFSA)11 is respon-
sible for providing independent scientific advice and com-
munication on food chain risks to risk managers and the
public. EFSA together with the European Centre for
Disease Control and Prevention (ECDC) collect annually
AMR data on humans, food and healthy animals from the
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EU Member States (MS) and some associated countries.
EFSA publishes “The European Union summary report on
antimicrobial resistance in zoonotic and indicator bacteria
from humans, animals and food”.12 EFSA also publishes
annually the “Trends and sources of zoonoses and zoono-
tic agents in foodstuffs, animals and feeding stuffs”13
report (“EFSA report” onwards) for those countries
which have not published this information.
The European Animal Health Study Center (CEESA)14 is
a non-governmental organization financed by the veterinary
pharmaceutical industry doing research on AMR. Two rele-
vant CEESA subsystems for this review are the VetPath mon-
itoring system and the European Antimicrobial Susceptibility
Surveillance in Animals (EASSA). CEESAmonitors the anti-
microbial susceptibility of major disease-causing bacterial
pathogens in food animals (VetPath), and of foodborne and
commensal bacteria in food animals (EASSA).
The European Antimicrobial Resistance Surveillance
Network (EARS-Net)15 is an AMR surveillance network
in accordance with the legislation16 for Europe and for the
European Economic Area members.17 Through EARS-
Net, the ECDC collects AMR data from the EU Member
States and publishes the annual EARS-Net report
“Surveillance of antimicrobial resistance in Europe”
which presents resistance percentages and trends for key
resistant bacteria. Data are based on blood and cerebrosp-
inal fluid isolates from humans.18
The European Medicines Agency (EMA), EFSA and
ECDC have produced two joint inter-agency antimicrobial
consumption and resistance analysis (JIACRA) reports19
attempting to compare antimicrobial use in animals and
humans to AMR in the sectors and to assess potential effects
of AMU and AMR in animals on the situation in humans.
Spain
The Spanish Veterinary Antimicrobial Resistance
Surveillance Network (VAV)14,20 was created to monitor
AMR. It consists of three programs dealing with healthy
animals, sick animals and with food and it is performed by
the Ministry of Agriculture, Fisheries and Food
(MAPAMA). VAV submits non-clinical data to the EFSA
that are included in the annual EFSA reports.
The MAPAMA publishes the annual zoonoses and
antimicrobial resistance report.21 This report is based on
the annual EFSA report and informs on zoonotic patho-
gens and diseases in animals, humans and food in addition
to data on AMR in some zoonotic bacteria and indicator
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The Spanish national plan to tackle and reduce AMR
(PRAN)24 has been set up by the Spanish Agency
for Consumer Affairs, Food Security and Nutrition
(AECOSAN). PRAN publishes a simplified report on zoo-
noses and antimicrobial resistance of chickens and turkeys for
poultry professionals and a simplified report on zoonoses and
antimicrobial resistance of laying hens for professionals in the
laying hen sector.21 In addition, PRAN publishes the JIACRA
Spain report25 which assesses the relationship between AMU
and AMR in humans and animals in Spain.
On the medical side, the national center of Carlos III
Institute (ISCIII) coordinates and manages the national AMR
database (EARS-Net-ES) submitting the data to the EARS-
Net.25
The Netherlands
The AMR monitoring system on animals and food in the
Netherlands is the “Monitoring of Antimicrobial Resistance
and Antibiotic Usage in Animals in the Netherlands”
(MARAN) bringing together the AMR food database of the
Food and Consumer Product Safety Authority (NVWA).26
The Netherlands publishes data on the resistance of
foodborne pathogens and of commensal indicators from
livestock and food in the annual report also referred to as
MARAN.27 The report is produced in collaboration with
the NVWA, the National Institute for Public Health and
the Environment (RIVM), the Netherlands Veterinary
Medicines Institute (SDa), the University of Utrecht and
Wageningen University and Research.
In the human sector, the Infectious Disease Surveillance
Information System on Antibiotic Resistance (ISIS-AR)28,29
aims at monitoring AMR in major pathogens. The Dutch
Foundation of the Working Party on Antibiotic Policy
(SWAB) publishes the annual report “Consumption of anti-
microbial agents and antimicrobial resistance among medi-


















Figure 1 Overview on AMR systems in livestock in six European countries. Inner ring systems (dotted sections) report AMR data to EFSA while outer ring systems not. For
details on the systems and their relationship, see the body of the text.
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This report provides resistance data for outpatients, inpatients
and care in nursing homes. It reports on several surveillance
programs such as the ISIS-AR and Mycobacterium tubercu-
losis surveillance program and others. It has been created by
the Ministry of Health, Welfare and Sport and the Dutch
Society of Medical Microbiology (NVMM) and coordinated
by the RIVM.
United Kingdom
Several systems and reports coexist to monitor AMR in
animals in the UK, which is based on the EU decision.30
The EU harmonized surveillance system (a native UK
system) collects mandatory AMR data on indicator com-
mensal Escherichia coli and/or Campylobacter spp. from
meat and faecal/caecal content of healthy animals
(chicken, cattle/beef, turkey and pigs) in the UK. There
are also UK National Control Programs for Salmonella in
layers, broilers and turkeys, which are hosted in the EU
harmonized surveillance system.
In England and Wales the scanning surveillance system
Vet Pathogens APHA31 provides AMR data from diseased
animals provided for diagnostic services on a voluntary
basis by veterinarians covering all relevant bacteria and
animal species.
In Scotland, a surveillance system carried out by the
Scotland’s Rural College Veterinary Services and Capital
Diagnostics (SRUC) collects clinical isolates from
animals.
In Northern Ireland, an AMR surveillance system per-
formed by the Agri-Food Biosciences Institute (AFBI)
collects livestock clinical data from post-mortem investi-
gation of colibacillosis or similar diseases. E. coli isolates
mainly originate from samples coming from less than
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Figure 2 Overview on AMR systems in humans in six European countries. Inner ring systems report (dotted sections) AMR data to EARS-NETwhile outer ring systems not.
For details on the systems and their relationship, see the body of the text.
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The annual report “UK-Veterinary Antibiotic Resistance
and Sales Surveillance” (UK-VARSS) promoted by the UK
government and produced by the Veterinary Medicine
Directorate (VMD) provides details on veterinary AMR
and AMU data in the UK.32
On the human side, the Resistance Surveillance Program
of the British Society for Antimicrobial Chemotherapy
(BSAC)33 publishes antibiotic resistance data from partici-
pating laboratories in the UK and Ireland for a range of
clinically significant bacteria from respiratory infections
from the community (since 1999), hospitals (since 2008)
and bloodstream infections (since 2001).
Public Health England’s Second Generation
Surveillance System (SGSS) captures routine laboratory
surveillance data on infectious diseases and antimicrobial
resistance from 98% of National Health Service (NHS)
laboratories across England. SGSS data are reported
annually in the English surveillance program for antimi-
crobial utilization and resistance (ESPAUR) report.34,35
The Electronic Communication of Surveillance in
Scotland (ECOSS) database collects AMR data from par-
ticipating NHS and reference laboratories in Scotland.36
The data are published together with the AMR data on












Figure 3 Overview on AMR systems in food in six European countries. Ring systems (dotted sections) report AMR data to EFSA. For details on the systems and their
relationship, see the body of the text.
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from humans in the Scottish One Health Antimicrobial
Use and Antimicrobial Resistance (SONAAR) report.37
The medical AMR data in Northern Ireland are col-
lected on a voluntary basis by the CoSurv database. These
data are published annually in the “Surveillance of
Antimicrobial Use and Resistance in Northern Ireland”
report (“NI report”). This report was published for the
first time in 2017 by the Public Health Agency (PHA).
Finally, the DataStore is an open-access database that
collects on a voluntary basis AMR data fromWales covering
all hospital labs. The DataStore data are annually published
in the “Antibacterial Resistance in Wales” report.
Norway
The Norwegian Surveillance System for Communicable
Diseases (MSIS)38 together with the Norwegian
Surveillance System for Antimicrobial Drug Resistance
(NORM) and Norwegian Veterinary Antimicrobial
Resistance Monitoring (NORM-VET) system are the
three AMR surveillance programs in Norway.39 These
systems publish their data in the “Usage of Antimicrobial
Agents and Occurrence of Antimicrobial Resistance in
Norway” (NORM/NORM-VET) report.40 This annual
report provides updated data on the occurrence and dis-
tribution of AMU and AMR in the human, animal and
food sectors.
France
The French Agency for Food, Environmental and
Occupational Health & Safety (ANSES) monitors AMR
data associated with farming, food and the environment.43
This institution coordinates the French surveillance net-
work for antimicrobial resistance in pathogenic bacteria of
animal origin (RESAPATH) and the Salmonella network.
In addition, ANSES collects AMR non-clinical data from
the national programs and the Salmonella network to be
submitted to the EFSA.
The Salmonella network is a surveillance system set up
to control non-human Salmonella throughout the food
chain. Samples are collected from healthy animals, food
and the environment.
The passive voluntary surveillance system RESAPATH
provides in the annual RESAPATH report the AMR data
compilation for the primary bacterial species and general
isolates from sick animals from each animal sector.41 This
surveillance system started in 1982 under the name of
RESABO (only for bovine species). In 2000, it was
extended to pigs and poultry and in 2007 to other species
including small ruminants, horses and companion animals.
This network collaborates with the National Observatory
of the Epidemiology of Bacterial Antibiotic Resistance
(ONERBA).
On the medical side, ONERBA is the annual French
report on AMU and AMR as well as the main AMR
network collecting data from a complex network of sub-
systems. Currently (2019), the French health system (SPF)
is taking over the ONERBA network and results are
reported in the new tool ConsoRes.42 This tool has been
set up by the support centers for the prevention of health-
care-associated infections (CPias) Great East and New
Aquitaine. Additionally, the AMR community network
driven by SPF reports results using the Medqual43 tool
coordinated by the CPias Pays de la Loire. Finally, the
Alert, Investigation and Surveillance of Nosocomial
Infection Network (RAISIN)44,45 coordinates nationally
the nosocomial infection surveillance coordination centers
(CCLIN), now CPias. The RAISIN network includes sev-
eral surveillance system modules. The private RAISIN
module for multi-drug resistant bacteria BMR-RAISIN
reports on AMR data in the community. However, it will
be replaced shortly by the tool ConsoRes (2019).46
Germany
The German veterinary monitoring system (GERM-VET)
collects clinical AMR data in Germany from companion
and food-producing animals. These data are published in
detail by the Federal Office of Consumer Protection and
Food Safety (BVL) in a report with the same
denomination.47
AMR-testing in the Zoonosis-Monitoring system
(ZOMO) is carried out by the Federal Institute for Risk
Assessment (BfR). The results are published in the annual
zoonosis monitoring report by the BVL.48 The report con-
tains data about zoonotic and commensal bacteria in
diverse food chains that are also reported to the EFSA
together with AMR-data on Salmonella from the national
control programs.
Antimicrobial Resistance Surveillance (ARS)49 is the
national AMR surveillance system in human medicine.
Established by the Robert Koch Institute, it collects rou-
tine susceptibility data for all bacterial species from any
kind of sample site from hospital care as well as from
outpatient care institutions by an increasing number of
laboratories participating on a voluntary basis. Results
for main pathogens are published via an interactive data-
base on the ARS website.
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Besides the national surveillance ARS, the federal state
Lower Saxony sets up a similar system (ARMIN).50
A further system has recently been set up in Bavaria
(BARDa).51
The Hospital Infection Surveillance System (KISS) is
the nosocomial infection surveillance system in hospitals
formed by several sub-systems collecting AMU and AMR
data.52 This network assimilated the Surveillance of
Antimicrobial Use and Bacterial Resistance in Intensive
Care Units (SARI).53,54 SARI collected on a voluntary
basis aggregated data on antimicrobial sensitivity for
selected pathogenic bacteria and AMU-AMR develop-
ment. The project is organized by the Institute for
Hygiene and Environmental Medicine of the Charité,
Berlin.55 Patient-based and unit-based AMR data
(MRSA, VRE, ESBL) are collected as well.
Finally, the Paul Ehrlich Society for Chemotherapy
(PEG)56 is a society that conducts studies on antimicro-
bial resistance in human pathogens as part of
a longitudinal study in both hospital and community sec-
tors. Results are presented as an interactive database on
the PEG website. The report on Antibiotic Consumption
and the Spread of Antibiotic Resistance in Human and
Veterinary Medicine in Germany (GERMAP),55 a joint
work of the PEG, the BVL and Infectiology Freiburg, is
published on a regular basis. This report provides AMU
and AMR data and trends in human and veterinary med-
icine in Germany since 2008. GERMAP publishes AMR-
data mainly from GERM-VET, ARS and data of the PEG.
The report publishes antibiotic consumption data from the
community analyzed by the Research Institute of the




A general overview on AMU monitoring and surveillance
systems is provided in Table 2. The variables collected in
the AMU table are country/region, database name, data
origin, unit, public data published report, report language,
data source, submitting data to Europe and set-up year of
the database. Additionally, Figures 4 and 5 show AMU
systems reporting and not reporting to EU per country and
sector.
The term “prescription data” has been used in the
veterinary field in the later table as “usage data” covering
what is prescribed by the veterinarian, supplied by the
veterinarian under veterinary prescription, or administered
by the farmer under veterinary prescription.
Europe
EMA monitors overall AMU in livestock through sales
data in the European Surveillance of Veterinary
Antimicrobial Consumption (ESVAC) project.57,58 Since
2010, AMU is provided as an overall consumption (ie
overall sales corrected for the animal population present
in the country) in mg/kg. Since 2019, European countries
are required to set up a data collection system in order to
provide antibiotic consumption per species to ESVAC
from 2022 onwards.
The Network on quantification of veterinary Antimicrobial
usage at herd level and Analysis, CommunicaTion and
benchmarkING to improve responsible usage (AACTING)
provides in its website guidelines and information on farm
level AMU collection systems from AACTING members,
mostly European countries.10
Similar to ESVAC, on the medical side, European
AMU data from the community and hospital sector are
collected by the European Surveillance of Antimicrobial
Consumption Network (ESAC-Net),59 that is coordinated
by ECDC. AMU data are collected by MS in the commu-
nity and the hospital sector or both (total care). In addition,
ECDC coordinates the Healthcare-Associated Infections
Surveillance Network (HAI-Net) since the coordination
of the Improving Patient Safety in Europe network
(IPSE) was transferred to ECDC in 2008. The HAI-Net
supports MS in the prevention and control of healthcare-
associated infections (HAI) and coordinates the European
point prevalence survey of HAI and AMU in acute care
hospitals, the European surveillance of surgical site infec-
tions (HAI-Net SSI), the European surveillance of
Healthcare-Associated Infections in intensive care units
and the repeated prevalence surveys of HAI and AMU in
European long-term care facilities.
Spain
The ESVAC-ES is a project from PRAN and carried out
by the Spanish Agency of Medicaments and Sanitary
Products (AEMPS).60 It collects animal AMU data on
a voluntary basis and reports annually these sales data
from the veterinary sector to ESVAC. Since 2019,
ESVAC-ES additionally collects prescription data.
Moreover, since 2016, several collaboration programs
between PRAN, MAPAMA and the animal production
sectors have been implemented. In these programs that
Dovepress Mesa Varona et al
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are called “Plan REDUCE” the animal sectors provide
AMU data on a voluntary basis to PRAN. These data
together with the prescription data that ESVAC-ES collects
will be submitted to ESVAC.
On the medical side, the Ministry of Health,
Consumption and SocialWelfare (MSCBS) database collects
community reimbursement data on antimicrobials dispensed
from only official prescriptions in the public system. The
system is run by the General Directorate of Basic Services of
the National Health and Pharmacy System.61 The database
for Pharmacoepidemiological Research in Primary Care
(BIFAP) and the Primary Care Clinical Database (BDCAP)
provide primary care data integrated into the MSCBS data-
base. Spain is able to provide primary and secondary care
sales data through The Human Data Science Company
(IQVIA) database, formerly Quintiles and IMS Health.24,62
The PRAN website provides charts based on data col-
lected from the latter databases with estimates on AMU in
hospitals since 2012 and in the community (national and
regional) since 2014.63
The Netherlands
TheMARAN report includes AMU data from two sources26:
● The Federation of the Dutch veterinary pharmaceu-
tical industry (FIDIN) provides antibiotic sales data
on the major livestock farming sectors.27
● The Netherlands Veterinary Medicines Institute
(SDa) is an independent institute that promotes
responsible drug consumption. It hosts a mandatory
delivery records AMU database on the main live-
stock sectors and publishes it in the SDa report.64
Similarly, Medirund,65 the central database for the
mandatory registration of antibiotics in cattle in the
Netherlands, reports AMU data quarterly.66
On the medical side, the NethMap report publishes AMU
data from electronic antibiotic prescriptions on patient
level.26 These are extracted from the Dutch hospital elec-
tronic prescribing system for hospitals by SWAB and from
the Foundation for Pharmaceutical Statistics (SFK) system
for the community. This report also assimilates data from
the national sentinel surveillance network for infectious
diseases in nursing homes (SNIV).67
United Kingdom
The VMD collates and analyses overall sales data from
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by species provided on a voluntary basis by several indus-
try-based databases. Both sales and usage data are pub-
lished in the UK-VARSS report. The industry-based
databases on pig, cattle and poultry are
● The Electronic Medicine Book for Pigs (eMB pigs),68
launched by the Agriculture and Horticulture
Development Board Pork (AHDB-Pork), collects
usage data at farm level from the pig industry in the
UK, covering around 90% of production.
● The British Poultry Council (BPC) Stewardship69
provides meat poultry usage data (for chickens, tur-
keys and ducks) in the UK, covering 90% of UK
poultry meat production.
● The British Egg Industry Council (BEIC) organizes
the collection of antibiotic usage data for the laying
hen industry. The Lion Scheme, representing over
90% of the UK laying hen industry, requires sharing
usage data with BEIC.
● FarmVet Systems is a private company, which col-
lects usage data from veterinary practice and this data
is published for cattle (dairy, around 30% UK cover-
age, and beef, around 5% UK coverage). This repre-
sents a convenience sample and so may not be
representative of the UK cattle industry.32
Additionally, the National Milk Laboratories (NML) data-
base collects AMU data at farm level in dairy cattle.70
However, this data source is currently at an early stage.
Likewise, the new eMB cattle and sheep database71 has
been set up during 2018 as a pilot project collecting usage
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Figure 4 Overview on AMU systems in livestock in six European countries. Inner ring systems (dotted sections) report AMU data to ESVAC while outer ring systems not.
For details on the systems and their relationship, see the body of the text.
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On themedical side, the NHSDigital database in England
displays antibiotic prescribing and AMR indicators from
general practice (GP). Additional primary care sources such
as hospices, nursing homes, police custody (among others)
are displayed in the ESPAUR report. The IQVIA database
shares secondary care data with Public Health England
(PHE). However, these data are not openly available.
In Scotland, the Information Service Division (ISD)
holds the Prescribing Information System (PIS) database
that provides AMU data from primary care. The data are
supplied by the Practitioner and Counter Fraud Services
(P&CFS) of the National System Scotland (NSS). This
system is responsible for the processing and pricing of
all prescriptions dispensed in Scotland. Data from second-
ary care are provided by the Hospital Medicines
Utilisation Database (HMUD) that is also held by the
ISD. Primary and secondary care data are published in
the SONAAR report.
In Northern Ireland, the Electronic Prescribing Database
and the JAC Medicines Management Systems are the two
datasets on AMU data from primary and secondary care,
respectively. Data are published in the NI report.
In Wales, the AMU data are collected from the pre-
scribing Information Data Warehouse for primary care
provided by the Prescribing Services Unit (PSU)72 and
the Medusa dataset73 for secondary care. Both are mana-
ged by Public Health Wales (PHW) and they cover 100%
of Welsh dispensing contractors and hospital pharmacies.
Norway
The NORM-VET monitoring system collects AMU data
from the Norwegian drug wholesales statistics database
WiDO















Systems not reporting 
to ESAC-NET
*Electronic Prescribing Information Data Warehouse
**Hospital pharmacies drug statistic database
















Figure 5 Overview on AMU systems in humans in six European countries. Inner ring systems (dotted sections) report AMU data to ESAC-NETwhile outer ring systems
not. For details on the systems and their relationship, see the main text.
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and the Veterinary Prescription Register (VetReg).40,74 The
latter register is owned by the Norwegian Food Safety
Authority (NFSA) and applies to veterinarians, pharmacies
and feed mills. There, prescription data on farmed fish (since
2011) and terrestrial animals (since 2012) are stored.
On the medical side, the NORM surveillance program
gathers AMU data in humans from the following surveil-
lance systems:
● The Hospital Pharmacies Drug Statistics Database.
● The national prescription database (NorPD)75 that
contains dispensed drugs in hospitals and nursing
homes from pharmacies in Norway.
● The Norwegian drug wholesales statistics database
that contains all sales data in Norway provided by
the Norwegian Institute of Public Health (NIPH).
Additionally, the Norwegian Surveillance System for
Antibiotic Consumption and Healthcare-Associated
Infections (NOIS) is a nationwide mandatory system
administrated by the NIPH. It is largely based on hospital
automated data extraction on AMU.
France
The French Agency for Veterinary Medicinal Products
(ANMV)76 within ANSES collects annually sales data on
veterinary drugs containing antibiotics in France, and also
reports these data stratified by animal species. ANMV uses
marketing authorisation holder estimates on the proportion
sold per target species. In addition, The Permanent
Observatory of Antibiotics in Veal Calf Farms77 is
a voluntary system collecting AMU data in veal calves.
Data are collected and analyzed by ANSES and the French
Livestock Institute (IDELE).
The French Pork Interprofessional Organization
(INAPORC)78 is a voluntary system gathering consump-
tion data on pig categories (sows, fatteners, weaners and
sucklers) from 160 randomly chosen pig farms (approxi-
mately 1% of French farms). This system is run by
ANSES, the swine industry’s French technical institute
(IFIP) and stakeholders. The results are delivered to each
farmer by the end of the study. Similar to INAPORC, the
GVET79 system is a voluntary pig register run by ANSES
and IFIP. The latter system also collects AMU data from
the same pig categories adopted by INAPORC providing
an online result access to farmers.
On the medical side, the national health insurance
cross-schemes information system (SNIIRAM) is a large
French healthcare database which covers around 99% of
the French population. SNIIRAM was extended with out-
patient data through the National health data system
(SNDS) by French law80 in 2016. The SNIIRAM-SNDS
dataset provides prescription data covering primary and
secondary care in the ambulatory and hospital sectors. It
includes systems such as CNAMTS (for employed work-
ers), RSI (for independent workers) and MSA (for farm-
ers) among others. Through CNAMTS, the MEDIC’AM
spreadsheet81,82 provides all medication reimbursement
data and also the costs to the system (overall and reimbur-
sement) and packages sold. SPF will take over shortly
SNIIRAM-SNDS (2019).
In parallel, The Antibiotic Consumption Monitoring
RAISIN module (ATB RAISIN) provides AMU data col-
lected on a voluntary basis from the hospital sector. It is
connected to the CPIAS network. It will be replaced
shortly by the tool ConsoRes (2019).46
The French National Agency for Medicine and Health
Products Safety (ANSM) publishes on a regular basis the
antibiotic consumption trends in France report.83 It
includes data on outpatient and hospital AMU in humans,
critical antibiotics and AMU in Europe. The data in the
report are extracted from the following databases: ANSM,
IQVIA, Permanent Sample of Medical Prescription
(EPPM), OPEN-MEDIC and ESAC-Net.
Germany
Several initiatives collect AMU data in Germany. The
animal antimicrobial sales data are reported annually by
the industry and wholesalers to the German Institute for
Medical Documentation and Information (DIMDI).84
The industry-based system run by Quality and Safety
GmbH (QS)85 carries out an antibiotic monitoring program
on AMU data in broilers, turkeys, ducks, veal and pork
productions. Some QS data are transferred to the Hi-Tier
(HIT)27 database. The HIT database is hosted by the
Bavarian Ministry for the Food Chain, Agriculture and
Forestry. The data collection includes treatment data on
pigs, turkeys, broilers and cattle. This AMU database
receives data from farmers and vets including the antimi-
crobial product, treatment days and number of treated
animals. From the data, benchmarks for AMU in the
different livestock sectors are calculated twice a year and
published by the BVL. These inform farmers on the neces-
sity to reduce AMU, ie farmers with a use above the third
quartile of all reporting farms of their sector need to take
action.
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The sentinel project Veterinary Consumption of
Antibiotics (VetCab)27,86 is carried out by the Institute
for Biometry, Epidemiology and Information Processing
of the Hanover University of Veterinary Medicine
Foundation (IBEI-TIHO). VetCab aims to describe and
assess AMU in farm animals in Germany and includes
data on pigs, cattle and broilers.
In the human sector, two national surveillance systems
are in place for hospital data: AVS (RKI) and ADKA-if-DGI.
The Federal Association of German Hospital
Pharmacists (ADKA) created together with the infectious
disease department of the University Freiburg the ADKA-
if project in 2007. Since 2015, the network supported by
the German Society for Infectious Diseases (DGI) is called
ADKA-if-DGI.87
The AVS87,88 housed by the RKI with technical sup-
port of the Charité collects data from German and Austrian
hospitals on antimicrobial consumption for individual sub-
stances and groups of substances in acute care hospitals
and rehabilitation centers since 2015 (2014 pilot study)
according to the German Infection Protection Act.
On behalf of the SHI (Statutory Health Insurance
Funds), the WIdO55,89 collects all antimicrobial prescrip-
tions from mandatory health-insured patients (totaling
about 89% of the German population). Only reimburse-
ment data from the ambulatory sector (about 85–90%) are
included in the WIdO dataset. Since 2001, all prescription
data have become available. WIdO data are yearly
reported to ESAC-Net via the RKI. In addition, the ZI,
a research institute of the Federal Association of Statutory
Health Insurance Physicians collects AMU data of ambu-
lant patients.
Discussion
Harmonization and Interpretation of the
AMU and AMR Data
Awide variety of AMU and AMR monitoring and surveil-
lance systems and reports were identified at country and
regional levels in the six countries. Funding of the systems
is mostly public, but may also be private.
Monitoring and surveillance databases are mostly not
freely accessible. Some databases do not report to the
public on a regular basis. Even when most of the reports
like NORM/NORM-VET, UK-VARSS, ESPAUR,
MARAN/NETHMAP, ARS, EARS-Net among others,
which publish aggregated data, are freely accessible others
like Medirund or EASSA reports are not. This lack of free
access to the available information may contribute to the
existence of overlap between systems, reports and data-
bases that may duplicate efforts and economic resources.
A further potential overlap source may be that the
development of the different systems is frequently due to
specific interests that are not fully covered by earlier
systems leading to a substantial diversity in objectives
and procedures. Therefore, it seems essential to reduce
the number of overlapping systems joining forces, promot-
ing synergies and planning the systems properly. Note that
some overlap between systems may also contribute to
validate system results. Some examples of overlapping
are presented in Table 3. In addition, often newer systems
are easier to use with the possibility of web-based report-
ing and feedback.
The presence of overlap between systems also trans-
lates to the existence of different reports that provide
information on the same type of data generated in different
systems. Furthermore, reports not based on a specific sys-
tem may also produce overlaps (eg GERMAP resistance
data on animals are also published by GERM-VET).
However, the level of reported information may be
different.
National AMU and AMR reports are published in
different languages (see Tables 1 and 2). Annual publica-
tion of these reports in an international agreed language
would facilitate access to published data.
AMR Surveillance and Monitoring Systems
AMR surveillance and monitoring systems vary substan-
tially between sectors and across the countries in the type
of data collected and reported. Besides the human, animal
or food population studied, main sources of variability
include the type of samples collected (clinical vs non-
clinical samples) and the sample collection basis (volun-
tary, sentinel or mandatory). Both define the bacterial
population that the isolates may be representative for and
influence the degree of representativeness of the data.
Diversity was also observed regarding the laboratory
methods (eg micro broth dilution, disk diffusion or other,
automatic systems) and the reported result type (minimum
inhibition concentration (MIC), inhibition zone (IZ) or
susceptible-intermediate-resistant (SIR)). The laboratory
method selected may affect final results. As an example,
colistin, a key antimicrobial in human and animal health,
diffuses poorly into the agar medium. Therefore, disk
diffusion results from colistin are not reliable.90
Quantitative data allow for interpretation using different
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clinical breakpoints (CBP) or epidemiological cut-offs
(ECOFF) as provided by EUCAST, CLSI or other, some-
times national institutions. SIR data can only be validly
compared to other SIR data, if the methodology used is
standardized. This includes both laboratory methods as
well as the ECOFFS or breakpoints used for the categor-
ization of the isolate populations to SR or SIR. Therefore,
AMR reports should capture quantitative data rather than
qualitative values (SIR or SR) to allow for interpretation
of data using different thresholds. However, the compar-
ability of quantitative data from different laboratory meth-
odologies remains as an issue.
Data collection systems often adopt a specific standard.
However, most standards and their corresponding evalua-
tion criteria do not cover all drug/bug combinations. In
that case, different standards and/or evaluation criteria
may be used for different drug/bug combinations in the
same data collection system. Therefore, AMR collecting
systems should have a similar approach (ie standard, eva-
luation criteria, antibiotic panel, unit and data type (clin-
ical-non clinical)) so that data comparison, evaluation and
analyses across countries and sectors were valid.
In addition, ECOFFs and CBPs are regularly revised,
so their threshold values may vary over time. Differences
between ECOFFs and CBPs are frequently underlined in
literature.91,92 ECOFFs identify the wild-type (those
assumed to have no acquired/mutational resistance) from
non-wild-type populations (those that show a degree of
acquired/mutational resistance) while CBPs define clini-
cally a microorganism as “sensitive”, “intermediate” or
“resistant” in relation to the likelihood of therapeutic suc-
cess. CBPs take into account information such as the
infection site, ability of the antimicrobial to reach the
infection site, dosage regimens and formulations available
to determine the effectiveness against the pathogen.
Therefore, interpretation of results between countries
may not be directly comparable as different dose regimens
are used.93 However, in most instances, the differences
between published ECOFF and CBP values are limited,
given that one dilution step is the tolerance of microdilu-
tion in both systems. Moreover, values for both evaluation
criteria are constantly evolving when new data become
available and those with the greatest differences (eg cipro-
floxacin in E. coli) tended to converge over time.94
The main task of surveillance systems is to provide an
overview of patterns and trends, however some systems
may provide additional useful information for risk factor
analysis.
A further source of variability identified on AMR sys-
tems is the collection of sample results from diverse
Table 3 Complementary Systems with Some Overlap
On the Human AMR
Sector








Germany ARS, PEG, MRSA-KISS, ICU-











x x FIDIN, SDa and
MEDIRUND
x x
Norway x The Norwegian drug wholesales statistics database, NorPD,













France BMR-RAISIN and ONERBA SNDS-SNIIRAM, ANSM, ATB-RAISIN ANMV, GVET and
INAPORC
x x
Spain x MSCBS and IQVIA ESVAC-ES and
Plan REDUCE
x x
Europe x x x x EASSA and
EFSA
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laboratories, using different diagnostic methods and inter-
pretation standards. Antimicrobial panels to be tested in
laboratories against zoonotic and commensal bacteria are
standardized in the livestock sector by Commission
Implementing Decision 2013/652/EU. This is not the
case in the medical sector and for the testing of clinical
isolates from animals. However, EU institutions clearly
indicate that the antimicrobial panel described for indica-
tor bacteria on livestock by Decision 2013/652/EU takes
human relevance into consideration.95 Therefore, reporting
part of the data adopting this standardized panel would
help minimize current standardization and harmonization
issues.
AMU Surveillance and Monitoring Systems
AMU collection systems are based on a variety of data
sources ranging from overall national sales data to indivi-
dual prescription or treatment data.7 Data are displayed in
very diverse units (such as weight of active ingredient,
therapy frequency, mg/Population Correction Unit (PCU),
Defined Daily Dose (DDD)/1000 inhabitants/days, DDD/
1000 Specific Therapeutic Group Age-sex weightings
Related Prescribing Units (STAR-PU) among others) ham-
pering the comparison of data from different sources.
Differences in dosage regimes and treatment durations
between hospitals and countries might result in an erro-
neous assessment of the treatment numbers if they are
deduced from the amount of drug sold. For these reasons,
any evaluation and comparison of AMU data from differ-
ent sources should be done carefully.
A consensus has been reached to report AMU data to
European level (ESVAC and ESAC-Net systems) adopting
the unit DDD/1000 inhabitants/days on the medical side
and antibiotic weight per population correction unit (mg/
PCU) on the animal side. However, as with breakpoints in
AMR, these units have drawbacks and the consensus is
a compromise that is continuously under debate.
The weight of the active ingredient as collected for the
ESVAC project does not account for its potency, ie the
amount needed to treat 1 kg of animal. Moreover, most
antimicrobials may be used in several animal species and
may also be licensed at a different dosage for different and
sometimes even for the same animal species. Sales data on
the veterinary side therefore only provide a general over-
view, but for further analyses, farm-level data are needed.
These are frequently collected on the regional or national
level as shown in Table 2, but at a very low level of
harmonization. At best they allow for assessing trends
within the system, but between systems analyses are very
challenging. This also applies for comparisons to the med-
ical side. The differences between the systems have repeat-
edly been described and critically reviewed.27,96
The DDD/1000 inhabitants/day is widely used as
a standard for monitoring antimicrobial consumption for
the human sector. However, it does not necessarily reflect
the dose prescribed to the individual patient. This particu-
larly plays a role for special patient populations (eg chil-
dren or patients with renal insufficiency). The same issue
applies for defined daily doses for animals. Dosing of
drugs for systemic use ideally should be done giving the
amount of drug needed per kg of treated individual. If the
weight of the treated animal is not accounted for and
DDDs are calculated from the amount of drug used
alone, substantial miscalculations are possible. In broilers
1-day-old chicks weigh about 50 g and 1-month-old broi-
lers around 2 kg, ie, that is 40 times more. If 1 kg of drug
dosed at 20mg/kg/day can be used to treat 1,000,000
1-day-old chicks, it will only serve 25,000 1-month-old
broilers. Using a standard weight for broilers at about 1 kg
(average weight at the time of treatment applied by
ESVAC) to calculate a DDD would result in 50,000
DDDs which neither reflects the exposure of 1-day-old
chicks nor the exposure of 1-month-old broilers.
Therapy frequency, used for farm animals in Germany,
on the other hand, has the drawback that it does not
account for dosing as it only considers the number of
animals that were treated with the drug, assuming that
this happens at a standard dose. DDDs, in case the DDD
are equivalent to the prescribed daily dose (PDD), and
therapy frequency both may represent days under treat-
ment, but the results may differ substantially when
describing the same population. This is because one is
based on counted treatment days and therefore the amount
of active substance used cannot be deduced from the
figure. DDD, on the other hand, is deduced from used
amounts of drugs and therefore does not have to be
equivalent to real treatment days because of the issues
explained above.
In summary, regarding antimicrobial use in animals,
there is need for a measure that includes the name of the
active ingredient, the amount of active ingredient,
the number of treated animals, the population at risk, the
weight of treated animals, the time under treatment and the
duration of the therapeutic effect of the active ingredient in
the body. If those are collected, most of the units that are
currently in use should be deducible from the information
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with a reasonable accuracy. Likewise, besides DDDs,
additional metrics should be collected in order to describe
the different aspects of AMU in the human sector (eg days
of treatment, number of prescriptions).
However, the EU agreed data type is not always pro-
vided in the national or regional surveillance and monitor-
ing system reports but other units such as DDD/1000
STAR-PU are.97
Those datasets that do not report their data at European
level may have different units than the agreed ones, such
as HIT or the SNIIRAM-SNDS system.
The health-care system implemented in each country is of
great relevance to understand the data collection. As an exam-
ple, in England, it is common to dispense outpatient medica-
tions by hospitals, whereas in Northern Ireland these are
usually prescribed by the GP at the request of secondary care
specialists.98 Thus, there may be significant dissimilarities in
the data collected across countries from homologous
databases.
The usage data per animal species is a more useful source
than sales data; however, it is not consistently collected by all
countries and also not provided to ESVAC yet. Collections of
these data are laborious if they are not available in electronic
formats. However, in most countries, prescription data are
collected at least from a part of the animal population such as
in the UK (collecting prescription data on a voluntary basis
from pigs through eMB pigs and meat poultry through BPC
stewardship), among others or Norway (mandatory data col-
lection of prescription data from food-producing animals in
VetReg and on a voluntary basis from companion animals).
However, the VetReg system has been compared to the sales
data and there is a proportion of underreporting among the
prescription data recorded since the registry started.99
Tools for Comparison
JIACRA analyses comparing AMU in animals and humans
to AMR in the sectors are accompanied by a long list of
disclaimers but provide a valuable general overview. Major
progress could further be improved by including prescription
data, or at least use data by animal species.
Diverse tools have been developed to assess correla-
tions and associations between AMU and the development
of AMR. As an example, the hospital-based ARVIA100
and Conso-Res are similar initiatives under development
in the human sector launched by Germany and France,
respectively. These efforts supplement the JIACRA reports
and address the issue at the hospital level.
Conclusions
● AMU and AMR Systems and Reports Need Further
Harmonization to Support the One Health approach.
● Availability of prescription data or similar for ani-
mals would allow a more detailed analysis of anti-
microbial treatment and resistance data, and enhance
interpretation of the findings published in the
JIACRA reports by EFSA, EMA and ECDC.
● In addition, major challenges need to be addressed in
order to harmonize AMU and AMR data in the animal
sector through uniform and robust standards that are
either fully harmonized or allow for conversion of data
to different units. To this end, for AMU, the name of the
active ingredient, amount of active ingredient, number of
treated animals, the population at risk, weight of treated
individual, treatment duration and the duration of the
therapeutic effect of the active ingredient in the body
are needed.
● AMR collecting systems should have as far as possible
a similar approach (ie standard, evaluation criteria, anti-
biotic panel, unit and data type (clinical-non clinical)) to
be compared, evaluated and analyzed across countries
and sectors. Otherwise, the data may not be directly
assessed. Additionally, reports on AMR should capture
quantitative values rather than data on the SIR level to
allow for interpretation of data using different thresholds.
However, there will be still an issue with comparability
of quantitative data from different methodologies.
● ECDC, EMA and EFSA indicate that the antimicro-
bial panel described for livestock by Decision 2013/
652/EU takes human relevance into consideration.
Reporting at least part of the data adopting this
standardized panel would ensure uniformity.
● Currently, there is some overlap between national and
international systems (see Table 3). Therefore, it seems
essential to join forces, promote synergies and plan the
systems properly in order to avoid overlapping and
address potential gaps making better use of the avail-
able resources. A first step to achieve the latter goal is to
address the system harmonization that will substan-
tially increase data sharing with the EU. It seems that
some resources could be used more efficiently by redu-
cing the number of overlapping systems. However, note
that some overlap between systems may be useful for
system and data validation.
● Preferably national AMU and AMR reports should be
published annually and provided in one international
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agreed language (eg English) to facilitate access to
published data.
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